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ABSTRACT 
 Staphylococcus aureus is a common pathogen that has the ability to infect 
virtually every tissue and organ system of the body. Despite its propensity to cause 
invasive infection, S. aureus is also a commensal organism, asymptomatically colonizing 
~25% of the population. Much research has gone into resolving this paradox, focusing on 
both human and bacterial factors that may contribute to colonization. Antimicrobial fatty 
acids present on the skin and in the nasal mucosa are important components of the innate 
immune system, and thus we undertook to further understand how S. aureus  responds to 
these fatty acids, and how this response facilitates survival during colonization, or 
promotes the transition from colonization to infection. Using physiological concentrations 
of several different fatty acids present on the skin and in the nasal mucosa, we assessed 
the response of community acquired methicillin resistant S. aureus (CA-MRSA) to long 
chain fatty acids. 25M of several unsaturated fatty acids including linoleic (C18:2), 
palmitoleic (C16:1), sapienic (C16:1), and linolenic (C18:3) added to the culture media 
was not growth inhibitory, yet caused a marked increase in the expression of the secreted 
proteases comprising the Staphylococcal proteolytic cascade (SPC). The increase in the 
expression of proteases was associated with the processing of the lipase glycerol ester 
hydrolase (Geh) into its mature form. This was not observed in a protease null mutant. 
 Growth in the presence of 50M linoleic acid caused a ~12h lag phase, after 
which the bacteria resumed a normal growth rate. Cells recovered after growth in 50M 
linoleic acid displayed permanent resistance to the same concentration of linoleic acid 
during subsequent growths, and these resistant strains each had single nucleotide 
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polymorphisms (SNP) present in their genomes, most commonly targeting the 
ribonuclease cvfA.  
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CHAPTER 1 – Literature Review 
1.1 Clinical relevance of Staphylococcus aureus 
The notoriety of Staphylococcus aureus as a pathogen began with its discovery in 
1880 by Scottish surgeon Alexander Ogston, as the causative agent of post-operative 
suppurative infections (1). Although the advent of antibiotics has reduced the mortality 
rate since that time, particularly the serendipitous discovery of penicillin by Alexander 
Fleming in 1928, S. aureus is now the worldwide leading cause of skin and soft tissue 
infections (SSTI). In addition to SSTIs, S. aureus is capable of infecting virtually every 
tissue in the body, and is also the leading cause of infectious mortality in North America 
(2, 3). While the prognosis of a S. aureus infection is usually optimistic, the incidence of 
infection is so high that the overall number of fatalities per year from S. aureus is greater 
than that of HIV in North America. Furthermore, in non-fatal incidences, treatment of a S. 
aureus infection can be difficult, necessitating an extended stay in hospital, and thus 
causing a severe burden on the health care system (2).  
The prevalence of S. aureus infection is in large part due to its ability to survive at the 
host pathogen interface. Approximately 25% of the population are persistent carriers of S. 
aureus, while up to 60% are transient carriers, predominantly in the anterior nares, but 
may also be colonized on the warm and moist areas of the skin, primarily the axillae and 
perineum (4, 5) . Importantly, patients with nosocomial S. aureus infections are often 
infected by the same strain that has colonized the skin or anterior nares (6)   
1.2 Description of S. aureus 
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Staphylococci are Gram positive, spherical, and non-motile bacteria that are ~m 
in diameter. They are distinguishable from other micrococci based on their propensity to 
form “grape-like” clusters. Ogston observed the micrococci while examining the pus of 
post-operatively infected patients, and appropriately termed the organism 
“Staphylococcus”, from the Greek term “Staphyle”, meaning “bunches of grapes”. The 
species Staphylococcus “aureus” was further defined by German surgeon Anton 
Rosenbach in 1884 after he observed the yellow pigmentation of the bacteria due to the 
pigment molecule staphyloxanthin(7) . S. aureus can also be distinguished from other 
staphylococci in simple laboratory tests via the detection of its production of coagulase, a 
protein which mediates the conversion of fibrinogen to fibrin through its interaction with 
prothrombin, and clumping factor, a cell surface protein that causes agglutination of the 
blood by direct binding of fibrinogen (8, 9).  
1.3 S. aureus genome 
S. aureus has a 60-70% mol A+T chromosome of 2.87 Mbp (10). Approximately 
75% of the genome is composed of ‘core’ chromosome, and the additional 25% consists 
of more variable mobile genetic elements such as prophages, insertion sequences, 
pathogenicity islands and plasmids (11, 12) . In general, the core genome consists of 
housekeeping genes, and virulence factors that are common to most strains of S. aureus, 
which include the lipase Glycerol Ester Hydrolase (Geh), proteases aureolysin, SspA, and 
staphopains A and B, alpha-hemolysin, and coagulase. Much of the genetic variability 
between strains is derived from the accessory genome, existing in the form of mobile 
genetic elements. Further genetic variability comes from DNA loss and mutation to 
existing genes. Evolution through MGE’s, DNA loss, and mutation to core chromosomal 
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genes has been crucial to the success of S. aureus as a pathogen, providing the bacteria 
novel virulence factors, antibiotic resistance genes, and tailoring some strains to become 
adept at survival in particular host niches (13). For example, methicillin resistant strains 
of S. aureus have acquired  - lactam resistance on the MGE known as the staphylococcal 
Cassette Chromosome SCCmec acquired via horizontal gene transfer from a coagulase-
negative Staphylococcus species (14, 15) , and several superantigen genes are encoded on 
prophage genes and pathogenicity islands (11, 16, 17) . Niche adaptation in some strains 
may have occurred due to DNA loss, and accumulation of pseudogenes that allow for 
host colonization at the expense of virulence (18)  
1.4 S. aureus paradigm of infection 
A hypothetical infection by S. aureus may be divided into three stages; i) 
colonization/attachment ii) tissue invasion/abscess formation and iii) metastatic infection. 
In addition to these, the bacteria are also faced with the burden of immune evasion across 
all three stages. Staphylococcal pathogenesis is multifactorial, and the ability of S. aureus 
to infect virtually every tissue of the body is mediated by its large endowment of 
virulence factors. Virulence factors come in the form of secreted proteins, membrane 
bound proteins, and cell surface components. 
First, colonization of the skin and anterior nares by S. aureus is a common 
precursor to infection, as demonstrated by the finding that patients with invasive 
infections are usually colonized by the same strain isolated from the site of infection (19, 
20) . Furthermore, colonized individuals are four times more likely to suffer from 
infection. Infection follows colonization through a breach in the host-pathogen interface, 
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and attachment of the bacteria to host tissue or extracellular matrix through cell wall 
associated adhesion proteins, which include members of the microbial surface 
components recognizing adhesive matrix molecules (MSCRAMM) family, which will be 
discussed in further detail in the next section. Examples of a breach in the host pathogen 
interface leading to infection include the inoculation of an open wound on the skin with 
colonizing bacteria, or an influenza-mediated damage in the mucosa of the respiratory 
tract, followed by infection with S. aureus resulting in pneumonia. 
  Tissue invasion and abscess formation is mediated by a range of secreted and cell 
surface factors that degrade host tissues (e.g. proteases), and seize nutrients via the 
breakdown of host factors (hemolysins, proteases, lipases). The formation of an abscess 
results from incoming neutrophils encapsulating the bacteria. Metastatic infection is a 
result of the escape of the bacteria from abscesses, through mechanisms which are not 
completely understood, but likely involves production of several secreted virulence 
factors, which include but are not limited to proteases, nuclease, lipase, leukotoxins, and 
small cytotoxins of the phenol soluble modulin family. This may result in septicemia and 
infection in almost any other tissue of the body. Throughout the course of infection, S. 
aureus may also secrete toxins that travel systemically resulting in toxinosis in the 
absence of metastatic infection, a classic example being toxic shock syndrome, caused by 
toxic shock syndrome toxin-1 (TSST-1) (21, 22) . 
1.5 Attachment and adhesion factors 
Attachment to host tissue components is a necessary step to S. aureus infection, 
and is mediated through cell wall associated virulence factors, in particular the microbial 
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surface components recognizing adhesive matrix molecules (MSCRAMMs) (23, 24) , 
fibronectin binding protein (FnBP), collagen binding protein (CBP), clumping factor (Clf) 
and extracellular fibrinogen binding protein. MSCRAMMs are anchored to the 
peptidoglycan by the enzyme Sortase A, which recognizes the LPXTG amino acid 
sequence near the C-terminus of peptidoglycan-bound proteins. Sortase A cleaves at the 
C-terminal end of the threonine residue, and catalyzes the formation of an amide bond 
between the threonine and an amino group on the peptidoglycan (24, 25) . The vast 
majority of peptidoglycan anchored proteins in S. aureus utilize sortase A and the 
LPXTG signal sequence, however S. aureus also maintains a second sortase enzyme, 
sortase B, which recognizes and anchors proteins with the signal sequence NPQTN. The 
only protein known to be anchored via this enzyme is the Iron-regulated Surface 
Determinant C (IsdC) protein (26)  
As its name suggests, FnBP binds to fibronectin, a glycoprotein of the 
extracellular matrix that is typically bound to integrins, but may also be associated with 
collagen and fibrin. Clumping factor associated with the cell wall, and the secreted 
extracellular fibrinogen binding protein both directly bind fibrinogen and cause 
agglutination. Attachment and agglutination may also cause emboli, and diseases such as 
infective endocarditis, where S. aureus attaches and accumulates on cardiac valves 
resulting in inflammation of the cardiac tissue. 
Attachment and agglutination allow for the assembly of high numbers of bacteria, 
which, as discussed later, is necessary for the expression of virulence factors responsible 
for the transition to invasive infection.  
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1.6 Tissue Invasion and metastatic infection 
            Tissue invasion and dissemination begins with the enzymatic breakdown and 
decrease in expression of the MSCRAMMs involved in attachment and adhesion, 
typically mediated by extracellular proteases (27, 28) . Host tissues are broken down by 
extracellular enzymes such as lipases, proteases, hemolysins, phospholipases, 
hyaluronidase, and nucleases. In addition to tissue invasion, these toxins also provide 
nutrients to the bacteria through the breakdown of host proteins, lipids and red blood 
cells. Abscess formation in host tissues follows, and the escape from abscesses further 
promotes metastatic infection and sepsis (29). 
Alpha-toxin, which is considered to be the major lethal toxin of S. aureus, exerts 
its cytolytic pore forming activity on red blood cells, oligomerizing to form a barrel in 
the cytoplasmic membrane, thus lysing the cell and releasing heme to be scavenged by 
the bacteria (30-32) . Studies have suggested that alpha toxin may be a candidate vaccine 
antigen, as the virulence of some of the most prevalent and virulent strains of S. aureus 
lacking the gene for hla was attenuated in a murine infection model, and immunization of 
mice against alpha-toxin reduced the severity of disease in a skin wound infection model 
(33) . Other hemolysins encoded on the core genome of S. aureus include beta-toxin, 
gamma hemolysin, and delta toxin. 
Leukocidins are also cytolytic pore forming toxins that cause lysis of neutrophils. 
These toxins typically consist of two components, S and F, which assemble in the 
membrane of white blood cells, forming a pore and leading to cell lysis (34) . The 
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significance of leukotoxins will be discussed further in the section on Community 
Acquired Methicillin Resistant S. aureus (CA-MRSA).  
            The expression of proteases and their role in S. aureus virulence will be discussed 
in further detail in a following section. 
1.7 Immune Evasion 
Both secreted and cell surface virulence factors are employed by S. aureus to 
evade the innate and adaptive immune systems. Examples of membrane associated 
immune evasion factors include carotenoid pigment, which resists extracellular reactive 
oxygen species produced in the oxidative burst of neutrophils (35) . Hydrogen peroxide is 
also detoxified by the enzyme catalase, which converts H2O2 to H2O and O2. 
Staphylococcal protein A (Spa) can be either membrane bound or secreted, and sequesters 
the Fc region of IgG antibodies, thereby preventing their opsonic binding to the cell 
surface (36, 37) . The 5 and 8 serotype capsular polysaccharide produced by S. aureus 
acts as a cloak to hide the bacterial antigens from the innate and adaptive immune 
systems, and clumping factor may also function in this capacity through the accumulation 
of fibrinogen at the cell surface (38-41) . Antimicrobial peptides of the innate immune 
system can be sensed by the antimicrobial peptide sensor (aps), causing an increase in the 
positive charge of the cell membrane via D-alanylation and lysine modification, thus 
repelling the positively charged AMP (42) . AMPs may also be degraded by extracellular 
proteases. Interference with the complement system is mediated through three proteins, 
Staphylokinase (SAK), chemotaxis inhibiting protein of Staphylococcus aureus (CHIPS), 
and staphylococcal complement inhibitor (SCIN) (43-45) . SAK can be either secreted or 
8 
 
 
cell membrane associated, and it converts the plasma protein plasminogen into the active 
form, plasmin (46) . Plasmin is an important human plasma enzyme that degrades other 
plasma proteins, most notably fibrin clots. However, plasmin may also degrade antibodies 
and AMPs, thus protecting the bacteria. CHIPS is a secreted protein that inhibits 
neutrophil chemotaxis by binding the C5a complement receptor and the N-formlyated 
peptide receptor located on the neutrophil cell surface. Both receptors, which are critical 
to attract neutrophils, are negated by CHIPS interference (47-49) . SCIN is also a secreted 
protein that interferes with the C3 convertase complex that forms on the cell surface of 
the bacteria. 
           More recently, small secreted molecules known as phenol soluble modulins 
(PSMs) have been the subject of debate regarding staphylococcal pathogenesis. PSMs are 
small peptides that polymerize to create pores in the cytoplasmic membranes of 
neutrophils, causing lysis(50, 51) .  
A more detailed discussion on proposed mechanisms of resistance to antimicrobial fatty 
acids follows in a later section.  
1.8 Regulation of virulence factors 
The expression of virulence factors during the attachment and invasive infection 
stages of staphylococcal pathogenesis is vastly different, and the shift from 
colonization/attachment to invasive infection is governed by the regulation of these 
virulence factors. Regulation is umpired by a complex network of two component 
systems, sigma factors, and other transcription factors that respond to environmental and 
cellular signals.  
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The most established and well-studied of these systems is the Accessory Gene 
Regulator (Agr) two-component system, of which the main function is triggering the 
positive expression of virulence factors contributing to invasive infection (52) . The Agr 
system is activated upon sufficiently high bacterial cell density using quorum sensing 
(53). Briefly, the agr locus contains four genes, directed by two promoters, P2 and P3. 
Transcription of agrBDCA is controlled by promoter P2, while P3 controls transcription 
of RNAIII, which is the effector molecule for downstream gene regulation (54) . 
Autoinducing peptide AgrD is processed, modified and secreted by the transmembrane 
protein AgrB (55, 56) , and at sufficiently high cell density, the concentration of AgrD in 
the local environment also becomes sufficient to stimulate the sensor protein AgrC. AgrC 
in turn phosphorylates AgrA, which is then able to bind and activate P2 and P3 (57) . 
Activated P3 stimulates increase in the production of regulatory RNAIII, which causes 
upregulation of genes involved in invasive infection such as proteases, hemolysins, lipase, 
and superantigens. Also embedded within the RNAIII transcript is the mRNA encoding a 
small cytolytic toxin -hemolysin, which is a member of the phenol soluble modulin 
family.  (54) 
Although a major regulator of virulence in S. aureus, Agr is only one of several 
two component systems present in the genome, including saeRS, srrAB, and arlRS (58-
60) .  The regulon of TCS saeRS overlaps with that of agr, and is induced in response to 
RNAIII. The environmental signals contributing to saeRS expression are not as well 
understood, but it has been demonstrated that its expression may be reduced in response 
to low pH, and its regulon overlaps that of agr. The TCS encoded by arl induces 
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autolysis, while downregulating agr (61) . srrAB is also an antagonist of agr, and is 
induced in response to low O2 (60).  
In addition to TCS, S. aureus also employs transcription factors and alternative sigma 
factors in the regulation of its virulence. S. aureus has several transcription factors, most 
notably the Staphylococcal accessory regulator (Sar) family of helix-turn-helix DNA 
binding proteins. This family contains 6 members, SarA, R, S, T, U, and V, but, specific 
mention will be made to only SarA here. SarA represses the transcription of proteases, 
and also effects the expression of RNAIII, thus indirectly regulating the expression of 
Agr-regulated genes (62) . Alternative sigma factors are also involved in the regulation of 
gene expression in response to environmental stimuli, most nobablyB, which is a major 
alternative sigma factor responding to environmental stresses such as energy depletion, 
and oxidative stress. In general, B causes a decrease in the expression of exoproteins, 
and an increase in many adhesion proteins. Importantly, B increases the expression of 
SarA, thus heavily decreasing the expression of secreted proteases, and is also required 
for carotenoid pigment synthesis. B mutants are thus completely deficient in pigment 
synthesis and are hyper-producers of secreted protease (63) . 
1.9 Antibiotic resistance 
              The combination of the virulence and staggering rates of antibiotic resistance of 
S. aureus has led to its appointment to the list of so called “Superbugs”. As stated earlier, 
the introduction of the beta lactam penicillin led to a large reduction in the mortality rate 
of S. aureus, due to its ability to bind and inhibit the transpeptidase (penicillin binding 
protein, PBP) that catalyzes the crosslinking of the peptidoglycan. However, two years 
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later penicillin resistant strains emerged, and today, more than 90% of S. aurues isolates 
are penicillin resistant (64). Penicillin resistance is mediated by a penicillinase, which 
breaks down the beta-lactam ring of penicillin, preventing it from inhibiting PBP (65) . 
To battle penicillin resistance, penicillinase-resistant antibiotics were produced, such as 
methicillin. However, methicillin resistant Staphylococcus aureus (MRSA) emerged in 
the United States and the United Kingdom in 1961, and as the name suggests, it is 
resistant to methicillin, and in fact all beta-lactam antibiotics. Beta-lactam resistance is 
mediated by the acquisition of an alternative PBP, PBP2a, that has less affinity for beta-
lactam antibiotics, thus rendering the treatment ineffective. PBP2a is encoded on the gene 
mecA, present on a pathogenicity island known as the Staphylococcal Chromosomal 
Cassette (SCCmec), likely acquired via horizontal gene transfer from Staphylococcus 
epidermidis (66) . Thus far, there are 8 different types of SCCmec elements discovered in 
S. aureus, which differ based on size and antibiotic resistance genes (67) . Although all 
SCCmec elements harbour the mecA gene, certain SCCmec elements have other mobile 
genetic element insertions that contain non-beta-lactam antibiotic resistant genes, such as 
SCCmec II and III (14) . Additional antibiotic resistance genes provide for further 
protection against antibiotics, although this comes at a fitness cost, and thus these strains 
may be less aggressive, but much more difficult to treat. Hospital associated methicillin 
resistant (HA-MRSA) strains characteristically have SCCmec types II and III, which 
carry additional antibiotic resistance genes (68). Community-associated methicillin 
resistant (CA-MRSA) strains typically have been associated with type IV SCCmec 
elements, although types V and VII have been found as well. These SCCmec types lack 
additional non-beta-lactam antibiotic resistance genes and the mobile genetic insertion 
elements that are characteristic of SCCmec types of HA-MRSA, and it is likely that this 
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contributes to their increase virulence and propensity to infect healthy individuals, 
although renders the bacteria more susceptible to antibiotic treatment then their HA-
MRSA counterparts (69) . 
1.10 CA-MRSA and USA300 
CA-MRSA, and strain USA300 in particular, are the most common cause of aggressive 
SSTI reporting to emergency rooms in North America (70-72) . In addition to the 
differences between CA-MRSA and HA-MRSA listed above, there are other factors that 
differentiate the two, and there is thus an ongoing debate in the literature that addresses 
these factors as possible causes of the increased virulence of CA-MRSA. These include 
higher production of virulence factors such as PSMs, the presence of the Panton Valentin 
Leukocidin (PVL) toxin, and in the case of USA300, the presence of the Arginine 
Catabolic Mobile Element (ACME) (73). Arguably, the most fiercely debated of these 
factors is the presence of the PVL encoding genes, lukS-PV and lukF-PV on a prophage. 
This is an obvious target because it is both a putative virulence factor, and is present in 
the vast majority of CA-MRSA strains, and absent in HA-MRSA strains. Literature has 
provided evidence both in favor of and against the notion that PVL is indeed the virulence 
factor that is responsible for the increased virulence of CA-MRSA. Specifically, in vivo 
infection models using rabbits have established that PVL is indeed necessary for 
virulence; however this has not been unequivocally supported in studies using murine 
models. It has been suggested that differences in sensitivity of leukocytes of different 
animals is the cause of this ambiguity (67, 73-77) .  
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The ACME is with a few exceptions, exclusively associated with USA300, and is 
physically linked to the SCCmec type IV element (78) . Present on this mobile genetic 
element is an arginine deiminase operon, and an oligopeptide permease operon, and it has 
been suggested that these may contribute to fitness of the organism. Specifically, the 
arginine deiminase pathway culminates in the release of an ATP molecule, and a basic 
NH3 molecule that may neutralize the acidic environment of the skin, and thus promote 
colonization. Oligopeptide permeases allow for the uptake of small nutrients in the form 
of small polypeptides. Although ACME may theoretically increase the fitness of 
USA300, this has yet to be unambiguously demonstrated, and thus is not generally 
accepted as a major cause of the increased virulence seen in USA300 (28, 79, 80) . It is 
perhaps more likely that ACME contributes to enhanced survival on the skin, and thus 
increased pervasiveness in the community. 
1.11 Staphylococcal proteolytic cascade 
The Staphylococcal Proteolytic Cascade (SPC) consists of three secreted proteases, the 
metalloprotease Aureolysin (Aur), staphylococcal serine protease A (SspA), and cysteine 
protease Staphopain B (SspB), with SspA and SspB in an operon along with a cognate 
inhibitor to Staphopain B, Staphostatin B (SspC), collectively forming the sspABC 
operon. The cascade is that of sequential activation of the proteases, culminating in the 
activation of SspB. The cascade begins with the production and autocatalytic activation of 
Aureolysin, which then activates SspA, and activated SspA then activates SspB cysteine 
protease(28, 81-83) .  
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Aureolysin is an M4 family metalloprotease and its 56 kDa precursor form 
becomes active via the autocatalytic removal of its 23 kDa propeptide, yielding a 33 kDa 
active enzyme. Activity of this protease depends on a Zn
2+
 in the active site, coordinated 
by His352 (84). As with other M4 metalloprotease family members, aureolysin often acts 
as a proprotein convertase, which serves to process and activate other enzymes, and also 
has a broad substrate specificity, preferring a hydrophobic amino acid at the P1 position.  
Although the activation of glutamyl endopeptidase SspA depends on aureolysin, proSspA 
is able to undergo initial steps of autocatalysis and these steps are necessary for the 
efficient final activation  by Aur. A glutamine rich segment between propeptide residues 
40 and 53 facilitates autocatalysis by the glutamyl endopeptidase, and preferred cleavage 
is at Gln43. This allows for the release of mature SspA by cleavage at Leu56, and then 
Val69 by aureolysin (82) . Mature SspA preferentially cleaves on the C-terminal side of 
glutamic acid residues, and controls adhesion of S. aureus by breaking down the 
MSCRAMM FnBP, thus contributing to invasive infection (83) , and also activates 
proSspB. 
Mature Staphopain B cysteine protease represents the fruition of the SPC. Secreted as an 
inactive precursor, proSspB’s activation depends on SspA cleavage on the C-terminal end 
of Glu220 on the propeptide of SspB (28) . Mature SspB performs a variety of functions, 
including the degradation of fibrinogen, collagen, the chemottractant chemerin(28, 85, 
86) , thus contributing to virulence. Staphopain B cleaves with the preference for arginine 
at the P1 position, and a bulky amino acid at P2 (83) . 
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The proteases of the SPC, along with another cysteine protease outside of the 
SPC, Staphopain A (ScpA), constitute the major proteolytic repertoire of S. aureus. 
Although the list of the virulence capabilities of protease has not been exhausted here, 
cumulatively, proteases contribute to infection by i) Controlling adhesion to host tissues 
ii) Acting as proprotein convertases, iii) Degrading plasma molecules contributing to 
blood clotting, and iv) Degrading immune system molecules. 
 1.12 Glycerol Ester Hydrolase and role of lipases in virulence 
The lipase Glycerol Ester Hydrolase (Geh) is expressed as a 72kDa precursor enzyme, 
and is processed into a 42kDa mature protein. Its annotated function is to break down 
triglycerides via the hydrolysis of the ester bonds between fatty acids and the glycerol 
molecule, and in this sense, it has been deemed to aid the bacteria in the breakdown of 
host tissues and the liberation of nutrients. Traditionally,  Geh has been dismissed as a 
significant virulence factor, and S. aureus researchers have even used geh as the target 
gene for the insertion of plasmids and expression of exogenous genes. However, it was 
recently demonstrated that a lipase mutant was less virulent in a murine model, and was 
also less able to form biofilms (87) . Apart from this, there has been no significant 
research into the contribution of lipases to virulence in S. aureus, or how lipases may 
promote colonization. 
1.13 Resistance to antimicrobial fatty acids 
In addition to other innate defenses at the host-pathogen interface such as low pH, high 
NaCl concentration and antimicrobial peptides, long chain fatty acids are abundant on the 
skin and in nasal secretions, and have been reported to be potent antimicrobials. Fatty 
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acids exist on the skin in sebum, which is a waxy substance secreted by the sebaceous 
glands and consists of ~28% free fatty acids, with the rest being composed of 
triglycerides, wax esters and squalene (88). In addition to the skin, there are also fatty 
acids present at M concentrations in nasal secretions, and mM concentrations in an 
abscess (89, 90).  Fatty acids have been identified as important components of innate skin 
defense, and patients with a deficient production of Sapienic acid (C16:16) on the skin 
were more prone to develop atopic dermatitis (91) , an inflammatory condition that is 
highly associated with S. aureus colonization. Fatty acids on the skin and in the nasal 
mucosa include myristic acid (C14:0), palmitic acid (C16:0), palmitoleic acid (C16:1), 
sapienic acid (C16:1), stearic acid (C18:0), oleic acid (C18:1), and linoleic acid (C18:2). 
These fatty acids are present in varying concentrations from individual to individual (89).  
Some bacteria are able to utilize fatty acids as a means of energy; however, this 
requires that the fatty acid be broken down into two-carbon acetyl-CoA molecules by 
beta-oxidation for entrance into the TCA cycle. According the annotated genome 
sequence, S. aureus lacks the enzymes necessary for beta-oxidation, and thus it is unlikely 
that S. aureus is able to break down fatty acids using this method (11, 78). In addition to 
utilizing fatty acids, some bacteria also produce and secrete fatty acids. Importantly, 
Lactobacillli of the nasal microbiota have been shown to produce conjugated linoleic 
acid, an isomer of linoleic acid (92-94), and Importantly, S. aureus must also compete 
with the nasal microbiota for colonization, including several phyla of bacteria, including 
Firmicutes, Proteobacteria, Bacteroidetes, and Actinobacteria. As an example of this 
competition, it has been shown that there is an inverse correlation of the amount of 
Staphylococcaceae and members of the Actinobacteria family (92). The differences in the 
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profile of microbiota between individuals may, in part, account for the differences in the 
composition of fatty acids of the nasal fluid, and these differences in the composition of 
the microbiota and fatty acid profile of the skin an nasal passage must be taken into 
consideration when putting this research into context. 
Literature thus far indicating mechanisms of resistance to fatty acids have 
typically found that the absence of a cell wall anchored element causes increased 
sensitivity to fatty acids, and thus implicates that element in resistance. The heme 
coordinating surface protein IsdA, S. aureus surface protein F (SasG), and teichoic acids 
have all been implicated in resistance to fatty acids (95-97). While the mechanism of 
resistance had not been demonstrated, it has been suggested that this is due to the physical 
presence of the cell surface proteins acting as a barrier to fatty acids. 
The most demonstrable and specific known mechanism of resistance to fatty acids 
is the Fatty Acid Modifying Enzyme (FAME). The FAME is an enzymatic activity that 
can be detected in 80% of S. aureus strains, and is characterized by the esterification of a 
fatty acid to a free hydroxyl, usually on a cholesterol molecule, thus detoxifying the fatty 
acid (98, 99) . In spite of the knowledge of FAME’s existence since the 1980’s, the 
enzyme itself has never been isolated, nor has the genetic component been identified. The 
enzymatic activity of this enzyme is to perform an esterification reaction, optimally at a 
low pH (5.5-6); both properties opposing those of traditional lipases which have optimal 
esterase activity at a high pH (99-101) . In keeping with traditional virulence factors, and 
similar to Geh, FAME activity seems to be dependent on induction by Agr (102), and it 
has been shown that FAME producing strains are more virulent in a murine model than 
strains in which FAME is not detected (99) . 
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HYPOTHESIS and OBJECTIVES: 
Exposure of Staphylococcus aureus to long chain antimicrobial fatty acids will invoke an 
adaptive response that ultimately contributes to persistence on the skin and in the anterior 
nares, and promotes the shift from colonization to infection. 
 
Objective 1: Assess the growth of clinically relevant strains of S. aureus in the presence  
                     of physiological concentrations of fatty acids present on the skin and in the   
                     nasal mucosa. 
Objective 2: Determine the effect of fatty acids on virulence factor production by S.  
                      aureus 
Objective 3: Determine the significance of differentially expressed virulence factors and  
                      the mechanism of S. aureus resistance to fatty acids. 
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CHAPTER 2 
 
Induction of the Staphylococcal Proteolytic Cascade by unsaturated fatty acids in 
community-acquired methicillin resistant Staphylococcus aureus 
 
 
 
 
 
Work presented in this chapter has been published in PLoS ONE 
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2.1    INTRODUCTION 
Staphylococcus aureus has a dichotomous relationship with humans. It is a 
ubiquitous commensal that persistently colonizes 25%-30% of the human population (1), 
yet it also has a broad arsenal of virulence factors (2), which enable it to be a leading 
cause of infections, ranging from relatively mild skin and soft tissue infections, to severe 
and life-threatening conditions such as necrotizing pneumonia, osteomyelitis, and 
infective endocarditis (2,3). The preferred site of colonization is the anterior nares, and 
infections are typically a consequence of autologous nasal carriage (4). Significant effort 
has therefore been directed towards identifying host and microbial factors that determine 
the carriage or non-carriage status (1,5,6,7,8,9,10,11,12), and in this context, our study is 
based on two broad assumptions. First, in order to maintain a persistent carrier status, S. 
aureus must endure innate defense mechanisms of the skin and mucosal surfaces, and 
from this, it follows that highly invasive pandemic strains of S. aureus should possess 
effective means of responding to these innate defense mechanisms. 
The USA300 strain of community acquired methicillin resistant S. aureus (CA-
MRSA) is well suited for testing these tenets of virulence and transmission. For 
approximately 30 years after the emergence of methicillin resistance, MRSA were 
restricted to the hospital environment, and these hospital-associated MRSA evolved by 
acquiring resistance to multiple antimicrobial agents (13,14,15,16). However, beginning 
in the 1990’s, the epidemiology of MRSA colonization and infection has undergone a 
paradigm shift with the rapid emergence and pandemic community transmission of the 
USA300 strain of CA-MRSA, which is known for causing aggressive skin and soft tissue 
infections that can progress to fatal complications if not rapidly treated (17,18). USA300 
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is now the leading cause of visits to hospital emergency departments in North America, 
for treatment of skin infections (19), and is displacing less virulent HA-MRSA, 
potentially aided by its ability to establish asymptomatic nasal carriage in health care 
workers (20). USA300 is more easily transmitted to household contacts compared to 
other S. aureus genetic backgrounds (21), and this study which surveyed the inguinal area 
in addition to the anterior nares, would have missed 51% of MRSA colonized persons if it 
had been conducted on a nares-only basis (21), which supports the contention that the 
rampant community transmission of USA300 could be due in part to a superior ability to 
persist on skin surfaces. A portion of this success is attributed to the arginine catabolism 
mobile element ACME, which uniquely confers resistance of USA300 to antimicrobial 
polyamines (22), and has been proposed to facilitate persistence on skin through 
catabolism of arginine with concomitant release of ammonia to neutralize acidic pH 
(23,24,25). 
Another barrier to persistence of bacteria on skin is the antimicrobial properties of 
sebum (26,27), which is a liquid phase lipid mixture secreted from the sebaceous glands, 
consisting of approximately 28% free fatty acids, 32% triglycerides, 25% wax esters, and 
11% squalene (28). In sebum triglycerides and free fatty acids, the major component is 
sapienic acid (C16:16), which is an isomer of palmitoleic acid (C16:19), and exhibits 
the primary antimicrobial activity (27). The importance of sapienic acid as an innate 
defense mechanism is evident in atopic dermatitis, where the skin is deficient in this fatty 
acid (29), and there is a near 100% recovery of S. aureus from the skin of atopic 
dermatitis patients. S. aureus is also exposed to antimicrobial fatty acids in colonization 
of the anterior nares, where palmitoleic (sapienic) and linoleic acid (C18:2) were 
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identified as the major unsaturated free fatty acids (uFFA) in human nasal secretions (30). 
Linoleic acid also accumulates to high levels within S. aureus abscesses (31), and abscess 
formation is a hallmark of S. aureus infection of the skin and soft tissues. 
Although exposure to antimicrobial fatty acids would be one of the first signals 
encountered by S. aureus during colonization of the skin or anterior nares, studies that 
have assessed the response of CA-MRSA to host-specific environmental signals have 
focused on stresses related to growth in blood, or phagocytosis by neutrophils (32,33). 
Therefore, the goal of this study was to evaluate how growth and production of secreted 
virulence factors by USA300 is influenced by exposure to physiologic levels of uFFA. 
Herein, we describe the robust induction of the staphylococcal proteolytic cascade 
pathway (SPC) in response to subinhibitory concentrations of uFFA in USA300 and other 
strains of CA-MRSA, and this response was also evident to varying degrees in clinical 
MSSA. The staphylococcal proteolytic cascade is comprised of a metalloprotease 
Aureolysin, which is needed to activate the SspA serine protease, which in turn activates 
the SspB cysteine protease that is co-expressed with SspA in the sspABC operon 
(34,35,36,37,38). We discuss the implications of this environmental signal-response 
pathway, and its potential impact on colonization, transmission, and the aggressive nature 
of skin and soft tissue infections caused by CA-MRSA. 
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2.2    MATERIALS AND METHODS 
2.2.1 Strains and growth conditions 
Bacterial strains and plasmids used in this study are defined in Table 2.1. Cultures 
were maintained as frozen stocks (-80ºC) in 20% glycerol, and streaked on TSB agar 
when required. TSB was supplemented, when necessary, with 10µg/mL erythromycin or 
2µg/mL tetracycline for propagation of strains bearing resistance markers. 
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Table 2.1 S. aureus strains and plasmids used in this study 
Strain Description Source 
RN4220 Restriction deficient lab strain (42) 
DU5969 RN4220aur::lacZ (48) 
USA300 LAC Hypervirulent pandemic CA-MRSA Los Angeles 
county clone, clonal complex CC8 spa t008 
(77,78) 
Barry Kreiswirth 
USA300 USA300 LAC cured of antibiotic resistance plasmid This study 
USA300aur::lacZ aur::lacZ from DU5969 transduced into USA300 This study 
USA300sspABC Replacement of sspABC in USA300 with Tc
r
 cassette, 
using pMJ232 
This study 
USA300aur Transduction of aur::lacZ into USA300 This study 
USA300sspABCaur Transduction of aur::lacZ into USA300sspABC This study 
USA400 CA-MRSA fatal pediatric bacteremia, CC1 spa t127 (79) 
MSSA476 CA-MSSA closely related to USA400; pediatric 
osteomyelitis 
(75) 
Newman MSSA clinical isolate; routinely used in virulence 
studies, CC8 spa t008 
(80,81) 
WBG10049 Southwest Pacific Clone of CA-MRSA, CC30 spa t019 (82) 
MRSA252 HA-MRSA; CC30, spa t016 (83) 
UAMS-1 MSSA osteomyelitis, CC30 spa t033 (84) 
SRI-138 MSSA dermatitis CC45 spa t065 (85) 
SRI-109 MSSA dermatitis; CC45 spa t015 (85) 
PED1-75 MSSA pediatric dermatitis; CC5 spa t002 (85) 
SRI-116 MSSA dermatitis; CC1 spa t7404 (85) 
SRI-142 MSSA dermatitis; CC1 spa t4938 (85) 
PED2-1 CA-MRSA pediatric dermatitis; CC97 spa t7398 (85) 
PED1-53 MSSA pediatric dermatitis; CC8 spa t008 (85) 
L528 MSSA infective endocarditis; CC30 spa t033 (52) 
PED1-37 MSSA pediatric dermatitis; CC398 spa t937 (85) 
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Table 2.1 Continued….. 
Plasmid Description Source 
pMAD Shuttle vector for construction of 
mutations in Gram-positive bacteria 
(41) 
pDG1514 Source of Tc
r
 cassette (86) 
pMJ232 pMAD containing Tc
r
 cassette from 
pDG1514, flanked by BamHI-(sspA-
5P)-MluI and EcoRI-(sspC-3P)-BglII 
This study 
 
2.2.2 Generation of plasmid-cured USA300 
USA300 LAC was a generous gift from Dr. B. Kreiswirth.  To facilitate 
mutagenesis in the USA300 genetic background, USA300 LAC was cured of the 27-kb 
plasmid (39), yielding USA300, which is sensitive to erythromycin, kanamycin and 
neomycin, using the method previously described (40). The plasmid cured USA300 LAC 
is referred to as USA300 throughout.  
Construction of USA300∆sspABC  
The sspABC operon encodes the SspA serine protease and Staphopain B cysteine 
protease SspB. For construction of USA300∆sspABC::tc, three DNA segments were 
assembled in pMAD, consisting of a 702-nt sspA 5'-flanking segment BamHI-(sspA-5P)-
MluI, a 2.1kb PstI- 1 193.27 
BT
1 0 0 1 197.35
35 
 
 
cgcggatccCGGTAAAGGATTTGTAAGGATTTCC-3') and sspA-5PR 
(5'-gcgacgcgtTTGCTGCTGGAGAACTCACAAGTG-3'), where the lower case residues 
in bold italics represent added BamHI and MluI restriction sites. Similarly, the 760 nt 
sspC-3P flanking segment was amplified with primers sspC-3PF (5'-
cccgaattcCAATTTCTCACCAGCTCG-3') and sspC-3PR (5'-
ggaagatctGTAGGTGAAGACCAAATCCCTCG-3'), incorporating respective EcoRI and 
BglII sites. After plasmid assembly in E. coli DH5, the resulting plasmid pMJ232 was 
transferred into S. aureus Newman via electroporation, using S. aureus RN4220 as an 
intermediate host. Construction of the sspABC::tc deletion mutation was conducted 
following protocols established for use with pMAD (41). The sspABC::tc deletion was 
confirmed by PCR with two primer pairs; one which flanks the external boundaries of the 
2.6-kb deletion, and the second which anneals within the deleted segment, and yields a 
product only with wild type genomic DNA. The sspABC::tc mutation was then 
transferred from strain Newman to USA300 using a phage 85 transducing lysate.  
2.2.3 Molecular biology protocols 
Protocols for plasmid construction in E. coli DH5 and genetic manipulation of S. 
aureus, including isolation of plasmid and genomic DNA, electroporation, and phage 
transduction have been described previously (35,36),(42). Restriction enzymes and DNA 
ligase were purchased from New England BioLabs, and AmpliTaq Gold DNA 
polymerase was purchased from Life Technologies. DNA amplification was conducted 
using a PTC-100 Thermal Controller (MJ Research). The integrity of cloned PCR 
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products was confirmed by sequencing of plasmid constructs at the London Regional 
Genomics facility of the Robarts Research Institute.  
2.2.4 TCA precipitation of proteins, SDS-PAGE, Western blotting and mass  
          spectrometry 
For SDS-PAGE analyses, proteins in the cell-free culture supernatant were 
precipitated by mixing with an equal volume of ice-cold 20% TCA, washed in ice cold 
70% ethanol, then air dried and dissolved in SDS-PAGE reducing buffer as described 
previously (37). The culture density (OD600) was determined prior to preparation of cell-
free culture supernatant, and for analysis of secreted protein profiles, TCA precipitated 
protein derived from 2.0 OD600 units of culture was applied to each lane of a 12% 
acrylamide gel. Identification of Coomassie-Blue stained proteins was conducted at the 
London Regional Proteomics Centre at Western University. Protein bands were excised 
using an Ettan™ Spot Picker, and processed for mass spectrometry using a Waters 
MASSPrep Automated Digestor as described (43). Processed samples were spotted on 
MALDI plates and analyzed on an Applied Biosystems 4700 Proteomics Analyzer. Data 
were acquired and processed using 4000 Series Explorer and Data Explorer (Applied 
Biosystems), and the peptide fingerprints were compared to the NCBInr database for 
Gram-positive bacteria, using the MASCOT search engine.  
For Western blotting, a volume of cell-free culture supernatant corresponding to 
0.02 to 0.05 OD600 units was mixed directly with SDS-PAGE reducing buffer, and 
applied to 12% polyacrylamide gels. Rabbit polyclonal antisera specific for SspA and Aur 
proteases was used as described previously (36,37), and rabbit polyclonal antiserum 
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specific for Hla was purchased from Sigma. Blots were developed with donkey anti-
rabbit IgG IR800 conjugate (Rockland Immunochemicals Inc.), and images were captured 
using an Odyssey infrared imager from LiCor Biosciences.  
2.2.5 Influence of fatty acids on growth of S. aureus  
Sapienic acid (cis-6-Hexadecenoic acid; 16:110) was purchased from Matreya 
LLC. Palmitic acid (hexadecanoic acid; 16:0), palmitoleic acid (cis-9-hexadecenoic acid; 
16:1), stearic acid (octadecanoic acid; 18:0), oleic acid (cis-9-octadecenoic acid; 18:1), 
linoleic acid (cis, cis-9,12-octadecadienoic acid; 18:2), linolenic acid (cis,cis,cis-9,12,15-
octadecatrienoic acid; 18:3) and glycerol monolaurate were all purchased from Sigma. 
Prior to supplementing TSB media, fatty acids were first mixed with an equal volume of 
DMSO, and then diluted in TSB to a working stock concentration of 5mM.  
For growth analyses, bacteria from single colonies on TSB agar were inoculated 
into culture tubes containing 3mL of antibiotic free TSB, and grown overnight at 37ºC on 
an orbital shaker, followed by measurement of OD600. A 25mL volume of TSB, 
supplemented with fatty acid where indicated, was then inoculated to achieve a starting 
OD600 of 0.01, and the cultures were grown 37ºC on an orbital shaker incubator, set at 
180rpm. Measurements of OD600 were taken at hourly intervals, and at set time points, 
samples were withdrawn for recovery of cell-free culture supernatant. All growth 
analyses were conducted in triplicate, from three separate cultures. 
2.2.6 Protease and -galactosidase assays  
Total protease activity in cell free culture supernatant was assayed with FITC-
casein substrate (Sigma Type II). Prior to assay, the supernatant samples were normalized 
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by dilution with sterile water as needed, to adjust for minor differences in cell density of 
the stationary phase cultures at time of harvest. Triplicate aliquots of the normalized 
culture supernatant (490µL) were mixed with 460µL of incubation buffer (40mM Tris-
HCl pH 7.4, 300mM NaCl, 20mM CaCl2, and 2mM L-cysteine) and 50µL of 0.2% w/v 
FITC-casein. Blanks were prepared using 490µL of sterile culture supernatant. The 
samples were incubated at 37°C in the dark for 2h. Trichloroacetic acid was then added to 
4% w/v to stop the reaction, and the samples were centrifuged at maximum speed for 15m 
to pellet undigested casein. The supernatant was then mixed with an equal volume of 0.5 
M Tris-HCl, pH 8.5, and after transfer to Optilux black clear bottom microtitre plates (BD 
Falcon), fluorescence was quantified on a Cary Eclipse Fluorometer using excitation at 
485nm and emission at 535nm.  
For -galactosidase reporter assays, USA300aur::lacZ was cultured in TSB or 
TSB supplemented with palmitic or palmitoleic acid, and 1mL aliquots were withdrawn 
at 5, 6, 7 and 8h of growth. After washing in 1mL of ice cold PBS, the cells were 
resuspended in 1mL of PBS, and transferred to Lysing Matrix B tubes containing 0.5ml 
of 0.1mm silica beads (MP Biomedicals). The tubes were placed in a FastPrep120 
homogenizer (Savant Biosystems) for 20s at a setting of 6.5. After centrifugation, a 20µl 
aliquot of each cell-lysate was added to triplicate wells of Optilux microtitre plates 
containing 50µM fluorescein-di--D-galactopyranoside (AnaSpec) in 150µL of 0.1M 
sodium phosphate buffer pH 7.3, 1mM MgCl2, and 45mM -mercaptoethanol. After 
incubation in the dark for 30 min, the assay was terminated by adding 50µL of 0.2M 
Na2CO3 to each well, and fluorescence was read using the Varian Cary Eclipse 
Fluorescence Spectrophotometer (Excitation/Emission = 490nm/520nm). 
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2.3 RESULTS 
2.3.1 Influence of fatty acids on growth of S. aureus USA300 
A recent study reported that the median concentrations of palmitoleic acid (C16:1) 
and linoleic acid (C18:2) were 48µM and 16µM respectively in human nasal secretions 
(30). Moreover, Kenny et al. reported that 10µM linoleic acid (LA) was not growth 
inhibitory, whereas 100µM LA inhibited growth of S. aureus strain MRSA 252 (44). We 
therefore chose this range of concentrations to assess the influence of LA and other 
saturated and unsaturated fatty acids on growth of USA300, a clinically important strain 
notorious for its ability to cause serious skin and soft tissue infections.  
Growth of USA300 was not influenced by up to 200µM saturated stearic acid 
(C18:0; data not shown), or by 25µM linoleic acid (Fig. 2.1A). However there was a 
sharp boundary between sub-inhibitory and growth inhibitory concentrations of linoleic 
acid (LA), and a concentration of 50µM consistently promoted a 12h lag phase, followed 
by unimpeded exponential growth. When viable cell counts were measured, there was a 
slight loss of viability over the first 8h of incubation in TSB containing 50µM LA, after 
which the culture began to recover, with initiation of exponential growth at 12h (Fig. 
2.1B). As reported by Kenny et al. (44), there was no growth at 100µM LA (data not 
shown), and this was also noted with linolenic, palmitoleic, and sapienic acid (Fig. 2.1D, 
E and F). The growth inhibition of sapienic acid closely resembled linoleic acid, with a 
50µM concentration promoting an extended lag phase followed by unimpeded 
exponential growth (Fig. 2.1F). The only exception to growth inhibition by uFFA was 
oleic acid, which was not inhibitory up to 200µM, and this is consistent with data from 
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Parsons et al., where S. aureus was cultured with 500µM oleic acid, albeit with use of 
BSA as a carrier (45). 
Saturated C16:0 palmitic acid was not inhibitory up to 200µM (Fig. 2.1G), 
confirming that antimicrobial activity is restricted to uFFA. A possible exception is lauric 
acid C12:0, which has been described as an antimicrobial component of human sebum 
(46). We therefore tested glycerol monolaurate as a source of C12:0, and found that 
growth was not affected by up to 100µM (data not shown), whereas 250µM permitted 
growth into late exponential phase, after which there was a rapid decline in cell viability 
(Fig. 2.1H). We conclude that unsaturated sapienic, palmitoleic and linoleic acid are the 
most effective inhibitors of S. aureus growth of the compounds studied, and the threshold 
between sub-inhibitory and growth inhibitory concentration occurs between 25µM and 
50µM, which approximates the median concentrations of linoleic and palmitoleic acid in 
human nasal secretions.  
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Figure 2.1: Influence of fatty acids on growth of USA300. Each point represents the 
mean of OD600 (A, C, D-G) or cfu/ml determination (B, H) from triplicate flasks of 
USA300 grown in TSB supplemented with the indicated amount of fatty acid; (), TSB 
only; (), 25µM; (), 50µM; (), 100µM; (), 200µM; (), 250µM. Lauric acid 
(C12:0) was provided in the form of triacylglycerol-monolaurate. Y-axes, OD600 or 
cfu/ml; X-axis, growth time (h). Error bars represent the Standard Error of the Mean. 
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2.3.2 Expression of secreted proteins is altered by uFFA 
As a means to understand the response of S. aureus to the various FAs, we 
examined protein expression profiles. While no significant changes were readily detected 
in whole cell lysate (data not shown), we readily observed that the profile of secreted 
proteins produced by USA300 was profoundly altered after growth to stationary phase in 
the presence of unsaturated sapienic (C16:16), palmitoleic (C16:19), linoleic (C18:2), 
oleic (18:1), and linolenic (C18:3) fatty acids (Fig. 2.2), whereas 100µM saturated 
palmitic acid (C16:0) or stearic acid (C18:0) had no influence on growth or profile of 
secreted proteins compared to TSB alone (Fig. 2.2A and C). These changes were clearly 
evident even at 25µM concentrations of uFFA that did not alter growth kinetics. As 
determined by mass spectrometry analyses of selected proteins, the most significant 
change upon exposure to uFFA was the appearance of a new protein corresponding to the 
SspA serine protease, which is co-expressed with the SspB cysteine protease in the 
staphylococcal serine protease operon sspABC (38), and this was especially evident with 
the C16:1 fatty acids, and 50µM linolenic acid. This was typically accompanied by loss 
or diminished production of a 72kDa precursor isoform of glycerol ester hydrolase, 
together with accumulation of 40kDa mature Geh.  
 A Western blot confirmed that production of SspA was up-regulated by the C16:1 
fatty acids, whereas saturated C16:0 had no effect, with SspA remaining in its slightly 
larger precursor isoform (Fig. 2.2B). Conversely, production of Hla was not influenced by 
either saturated or unsaturated fatty acids. From these data, we conclude that uFFA 
primarily influence the production of secreted proteases, concomitant with maturation of 
proGeh. 
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Figure 2.2 Influence of fatty acids on the protein production of S. aureus: SDS-
PAGE of secreted proteins (A, C) and Western blot for detection of SspA and Hla (B), in 
culture supernatant of USA300 after growth for 18-24h in the presence of C16 (A) or C18 
(C) fatty acids. Cultures were grown with the indicated amounts of C16:16 (sapienic 
acid), C16:19 (palmitoleic acid), C16:0 (palmitic acid), C18:2 (linoleic acid), C18:1 
(oleic acid), C18:3 (linolenic acid) or C18:0 (stearic acid) fatty acids. Proteins in the cell-
free culture supernatant were precipitated in ice-cold TCA, and after solubilization in 
SDS-PAGE reducing buffer, protein equivalent to 2.0 OD600 units of culture supernatant 
was loaded in each lane (A and C). For Western blot (C), 0.02 OD600 units of cell free 
culture supernatant were subjected directly to SDS-PAGE, prior to detection with specific 
antisera (see Materials and Methods). 
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2.3.3    The Staphylococcal proteolytic cascade (SPC) is induced by UFFa 
The SPC is initiated by autocatalytic activation of the metalloprotease Aureolysin 
(36). However, we have observed that mature Aureolysin is unstable, and its secretion 
and maturation precedes the appearance of proSspA and proSspB in culture supernatant 
(36). We therefore cultured USA300 and isogenic aur or sspABC derivatives in TSB for 
8h, to assess the influence of linoleic acid at an earlier time point (Fig. 2.3). In terms of 
the impact on secreted proteins, our data clearly establish that the primary effect of 
linoleic acid is to induce protease expression, as evident from the appearance of a new 
protein corresponding to Aur in USA300sspABC, and induction of SspA in USA300aur, 
while both proteins are produced in wild type USA300 (Fig. 2.3A). The only other 
obvious changes were alterations in the relative amounts of 72kDa proGeh in USA300 
and USA300sspABC after growth with linoleic acid, but this was less evident in 
USA300aur. This is consistent with a role for Aur in processing of proGeh, as reported 
for orthologous metalloprotease and lipase proteins in S. hyicus (47). 
Enhanced production of secreted protease was confirmed by assay of total 
protease activity in culture supernatant (Fig. 2.3B), which was significantly increased 
when USA300 was cultured with 25µM LA. Protease activity was also enhanced, 
although to a lesser extent, when USA300sspABC was cultured with 25µM LA, and this 
activity was inhibited with EDTA, confirming that metalloprotease is induced by LA. No 
increase in activity was evident when USA300sspABC-aur was cultured with LA, even 
though scpA encoding the Staphopain A cysteine protease was not targeted for disruption. 
Therefore, it appears that the influence of uFFA is specific to aur and the sspABC genes 
that comprise the staphylococcal proteolytic cascade (SPC), but does not affect 
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Staphopain A (ScpA), which does not comprise part of the staphylococcal proteolytic 
cascade, because it undergoes autocatalytic activation independently of other protease 
functions (35). 
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Figure 2.3 Growth in fatty acids results in increased production of the proteases of 
the SPC: SDS-PAGE and Western blot analyses of secreted proteins produced by 
USA300 and isogenic variants after 8h of growth in TSB, or TSB supplemented with 
25µM linoleic acid (A), and assay of total protease activity in culture supernatant (B). For 
(A), protein loading was 2.0 OD600 units for Coomassie staining, and 0.02 OD600 units for 
Western blots, which were developed with primary antibody specific for Aur,  and SspA 
as indicated. Arrows on the Coomassie stained gel indicate the selective induction of 
secreted proteases in response to linoleic acid. The arrow on the right margin indicates the 
position of proGeh. In (B), total protease activity in 8h culture supernatant of USA300 
and isogenic variants was determined with FITC-casein substrate. Cultures were grown 
with 25µM linoleic acid as indicated, and assay buffer was supplemented with 10mM 
EDTA where indicated, to inhibit metalloprotease. Data are reported as fluorescence 
emission at 535nm (535), measured in arbitrary fluorescence units. Error bars represent 
the Standard Error of the Mean. 
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To confirm that these changes occur at the transcriptional level, we took 
advantage of the aur::lacZ fusion created by inactivation of aur, which places lacZ under 
transcriptional control of the aur promoter (48). We cultured USA300aur in either TSB, 
or TSB supplemented with 25µM palmitic (C16:0) or palmitoleic acid (C16:1), taking 
samples between 5 and 8h, which as shown in Fig. 2.1E and 2.1G, corresponds to the 
transition between exponential growth and post-exponential phase. Assay of -
galactosidase activity in the total cell lysates revealed a clear induction after 8h when 
USA300aur was cultured with 25µM palmitoleic acid (Fig. 2.4). This experiment was 
repeated with replicates of three cell lysates for each growth condition, and after 8h of 
growth, palmitoleic acid promoted significantly greater -galactosidase activity compared 
to palmitic acid (p = 0.037) or TSB alone (p = 0.004), and there was no significant 
difference comparing growth in TSB alone versus TSB supplemented with palmitic acid 
(p = 0.090). Cumulatively, these data establish that uFFA induce expression of secreted 
proteases comprising the staphylococcal proteolytic cascade. 
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Figure 2.4 Expression of aureolysin is induced at the transcriptional level: -
galactosidase reporter gene assay in cell lysate of USA300aur after growth for 5-8h in 
TSB, or TSB supplemented with 25µM palmitic (C16:0) or palmitoleic (C16:1) acid. 
Error bars represent the Standard Error of the mean. * p < 0.01, **p < 0.05, *** p > 0.05, 
by Student’s T test. 
 
 
 
 
 
 
 
*** 
* 
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2.3.4    Induction of the Staphylococcal Proteolytic Cascade in response to uFFA is  
             characteristic of S. aureus clinical isolates 
To evaluate the response of other S. aureus strains to LA, we first tested another 
strain of CA-MRSA known as USA400, and a closely related strain of community 
acquired MSSA known as MSSA476, which are genetically distinct from USA300. These 
and other strains used for this analysis are defined in Table 2.1. After growth in TSB 
containing  LA, the culture supernatants of USA300, USA400 and MSSA476 each 
exhibited accumulation of a protein corresponding to SspA (Fig. 2.5A) as confirmed by 
Western blot (Fig. 2.5B), together with a marked decrease in proGeh, concomitant with 
appearance of mature Geh (Fig. 2.5A). Production of SspA by USA300 and MSSA476 
appeared to exceed that of USA400, and on several repetitions, USA300 always exhibited 
more robust production of SspA in response to LA, compared to USA400. Consequently, 
there are strain dependent differences in induction of the SPC in response to uFFA. We 
therefore tested additional strains to assess variation in SspA production in response to 
uFFA (Fig. 2.5C and D). 
Once again, induction of SspA in USA400 was less robust compared to USA300, 
although the overall impact on the profile of secreted proteins was similar, as noted from 
the marked reduction in accumulation of proGeh concomitant with induction of SspA 
(Fig. 2.5C). Strain WBG10049, representing the Southwest Pacific Clone of CA-MRSA, 
also exhibited robust induction of SspA (Fig.2.5C and 2.5D) concomitant with 
disappearance of proGeh, but this characteristic response was not readily observed in 
MSSA strains Newman and UAMS-1, or in HA-MRSA strain MRSA 252, which have 
been used as model pathogens to address virulence and gene expression in S. aureus. 
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Although these latter strains did not respond to LA, expression of secreted virulence 
factors in Newman is affected by a unique polymorphism in the saeRS regulatory locus 
(49), while UAMS-1 and MRSA 252 belong to a distinct clade within clonal complex 
CC30 characterized by altered signaling of the accessory gene regulator agr (50,51,52). 
We therefore tested an additional panel of S. aureus isolates obtained from the skin of 
adult or pediatric atopic dermatitis patients, and strain L528, which is genetically related 
to UAMS-1, and derived from a patient with infective endocarditis (Table 2.1). 
To varying degrees, with the exception of Newman, which was included as a non-
responsive control, each strain exhibited enhanced production of SspA when cultured in 
TSB supplemented with 25µM LA. In some of these, including SRI-109, PED1-75, 
PED2-1, and PED1-53, there was some production of SspA in TSB alone, which was 
slightly larger than the more abundant isoforms that were produced when cultured with 
25µM LA. This likely reflects our finding that SspA is secreted as an inactive precursor 
proSspA, and then undergoes a stepwise maturation that requires processing of the N-
terminal propeptide by Aureolysin. One of these strains, PED2-1, is a CA-MRSA that 
corresponds to clonal complex CC97, while the others are MSSA (Table 2.1). In 
consideration of these data, we conclude that variable induction of the staphylococcal 
proteolytic cascade pathway in response to uFFA is a characteristic trait of S. aureus 
clinical isolates, and that this response is particularly robust in the USA300 strain of 
CA-MRSA, which is known for causing aggressive skin and soft tissue infections. 
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Figure 2.5 Response of different strains of S. aureus to linoleic acid: SDS-PAGE and 
Coomassie staining (A and C), or Western blot for detection of SspA (B, D and E), in 
cultures of S. aureus grown in TSB containing 0 or 25µM linoleic acid (LA) as indicated. 
Protein loading was 2.0 OD600 units for SDS-PAGE, and 0.02 OD600 units for Western 
blot. The S. aureus strains are as defined in Table 2.1. Black arrows and labels on the 
right margins of panels A and C indicate the location of 72kDa glycerol ester hydrolase 
precursor (proGeh) and mature lipase (Geh). White arrows in Panels A and C point to 
SspA protein that is induced in response to 25µM LA. The SspA protein exhibits some 
expected variation in size, being comprised of 327 amino acids in USA400 (MW_0932), 
336 amino acids in USA300 (SAUSA300_0951), and 357 amino acids in MRSA252 
(SAR_1022) and other CC30 strains, due to variation in a C-terminal disordered segment 
comprised of tripeptide repeats. Different isomers produced by the same strain as shown 
on Western blot (2.5E), as explained in the text, are also attributed to varying degrees of 
processing of the N-terminal propeptide of the SspA precursor, proSspA. 
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2.4     DISCUSSION 
Our previous work defined the staphylococcal proteolytic cascade, comprised of a 
metalloprotease Aureolysin, which undergoes rapid autocatalytic activation, and is then 
needed to activate the SspA serine protease, which in turn is required to activate the SspB 
cysteine protease that is co-expressed with SspA in the sspABC operon (34,35,36,37,38). 
Cumulatively, the activities of these proteases are consistent with multiple functions 
related to modulation of adhesion, colonization, tissue invasion and immune evasion, 
which include degradation of complement and antimicrobial peptides (53,54), processing 
of phenol soluble modulins (55), degradation of microbial adhesion proteins (48,56) and 
their tissue ligands (34,57), and processing of kininogen to promote enhanced vascular 
permeability (34,58). The major findings of our present study are that (i), the SPC is 
induced by antimicrobial unsaturated long chain fatty acids uFFA, in four different 
genetic backgrounds of CA-MRSA; (ii), amongst CA-MRSA there is variable induction 
of the SPC in response to uFFA, with USA300 consistently exhibiting a more robust 
induction of SspA relative to USA400; and (iii) this response was also manifested to 
varying degrees by clinical MSSA, including pediatric osteomyelitis (MSSA476), 
infective endocarditis (L528), and several strains recovered from the skin of adult and 
pediatric atopic dermatitis patients. 
With respect to S. aureus persistence on skin, Sapienic acid (C16:16), which is 
an isomer of palmitoleic acid (C16:19), is the major fatty acid component of human 
sebum, and separate studies reported minimum inhibitory concentrations of 10-20µg/ml, 
and 30µg/ml respectively, for S. aureus (27,46). Another study reported the median 
concentration of palmitoleic acid in human nasal secretions as 12µg/ml (30), which 
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corresponds to 48µM. Based on these considerations and our present data, it is apparent 
that physiologic concentrations of palmitoleic, sapienic and linoleic acid are sufficient to 
induce the SPC in S. aureus, and this is unique to unsaturated fatty acids. Although S. 
aureus does not have the capacity for -oxidation of fatty acids, exogenous unsaturated 
fatty acids are transported across the cytoplasmic membrane through as yet unknown 
mechanisms, and then either directly incorporated into membrane phospholipid, or 
alternately, can be extended by the Type II fatty acid synthase machinery, prior to 
incorporation into phospholipid (45,59). Unsaturated fatty acids have reduced packing 
density in membranes, leading to increased membrane fluidity, and our data may reflect a 
mechanism for sensing changes in membrane fluidity. 
It is unclear whether induction of the SPC by unsaturated fatty acids represents an 
innate immune function of the epithelial barrier to infection, or whether this promotes 
colonization and virulence. Several studies have implicated a role for secreted proteases 
of S. aureus in promoting biofilm dispersal (60,61,62), and it has been suggested that the 
biofilm mode of growth promotes nasal carriage of S. aureus (63). Specifically, an 
extracellular serine protease Esp of S. epidermidis, which is orthologous to SspA, 
promoted S. aureus biofilm dispersal in vitro, and eradicated S. aureus nasal carriage in 
human subjects when administered intranasally. Although it has been debated whether 
this was due to biofilm dispersal, or degradation of adhesion proteins and their epithelial 
ligands (64), it supports the contention that nasal carriage could be regulated through 
induction of the SPC by unsaturated fatty acid in nasal secretions.  One study with a 
limited number of subjects, revealed a wide variance in the level of palmitoleic/sapienic 
acid in nasal secretions, ranging from 1.8 to 27µg/ml (30), which corresponds to 7.1µM 
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to 106µM. Therefore, it is reasonable to speculate that individuals with higher sapienic 
acid content would not carry S. aureus, due to a combination of antimicrobial activity and 
induction of the SPC, which would promote biofilm dispersal and interfere with microbial 
adhesion. 
Alternatively, induction of the SPC by uFFA could facilitate the initiation and 
maintenance of a stable carriage relationship. Importantly, the phenol soluble module 
(PSM) family of peptides produced by S. aureus exhibit antimicrobial activity towards 
Streptococcus pyogenes, which may comprise a mechanism of interference with 
competing colonizing pathogens, and the PSM peptides appear to require proteolytic 
processing by Aureolysin to activate their antimicrobial properties (55,65).  Moreover, 
individuals who are colonized by S. aureus also have elevated levels of host-derived 
antimicrobial - and -defensins in their nasal secretions (6). The antimicrobial peptide 
dermcidin, which is secreted from eccrine sweat glands, can induce expression of the 
SepA metalloprotease of S. epidermidis, and antimicrobial peptides also trigger protease 
production in S. aureus (66). In this situation, signaling is mediated through the 
antimicrobial peptide sensor aps (67,68), which also responds to glycopeptides (69,70), 
and triggers a global response that leads to modification of membrane lipids and cell wall 
teichoic acids, which cumulatively promote resistance to antimicrobial peptides. 
Therefore, induction of the SPC by uFFA could promote colonization, through 
degradation of host-derived antimicrobial peptides, concomitant with activation of the 
antimicrobial properties of PSM1 and PSM2, which function to eliminate competing 
pathogens. 
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In this context, the capacity for uFFA to induce production of secreted proteases 
appears to exceed that of other environmental signals, and to our knowledge this 
represents the only environmental stimulus identified thus far, that can lead to 
accumulation of SspA serine protease as one of the major secreted proteins. 
Transcriptional profiling studies have evaluated the transcriptome of USA400 CA-MRSA 
in response to neutrophil microbicides, including azurophile granule proteins, HOCl, and 
hydrogen peroxide, and although transcription of certain toxin genes, most notably 
encoding -hemolysin, was strongly induced by these signals, there was no major 
influence on transcription of sspA or aur (33), and similar observations were noted in 
assessing the transcriptome of USA300 in response to growth in blood (32). Therefore, 
our data allude to a novel signaling pathway that may selectively induce the SPC, which 
has an important role in modulating adhesion, colonization and invasion 
(34,38,48,53,56,57,71). 
Induction of the SPC was particularly robust in the USA300 strain of CA-MRSA, 
and in WBG10049 representing the Southwest Pacific clone of CA-MRSA, both of which 
cause aggressive skin and soft tissue infections, whereas induction of SspA was evident, 
but consistently less robust in USA400. Intriguingly, USA400 appears to be associated 
with septicemia, and disruption of the saeRS regulator in USA400 strongly attenuated 
virulence in a bacteremia model, but had no significant influence on virulence in a 
subcutaneous abscess model (72). These observations support the contention that the 
expression and role of subsets of virulence factors is strongly influenced by the site of 
infection. In this respect, it is noteworthy that S. aureus Newman has been used to 
evaluate the genetic requirements for kidney abscess development (73,74), establishing 
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the importance of Coagulase and vonWillebrand Factor binding protein in promoting the 
formation of a fibrin pseudocapsule that impedes migration of neutrophils into the 
microbe dense core of the abscess (73). However we, and others, have defined a role for 
secreted proteases in degrading fibrin, and cell surface fibrinogen binding proteins 
(34,48,57), and abscess tissue has high levels of uFFA, of which the major bactericidal 
activity is attributed to linoleic acid (31). Therefore, we must consider that the ability of 
strain Newman to form large, well defined abscesses could be due in part to its failure to 
induce protease expression in response to uFFA, as we have demonstrated in this study. 
MRSA 252, which is a successful epidemic strain of HA-MRSA (75), also failed 
to induce the SPC in response to linoleic acid. Strikingly, MRSA 252 was used to 
evaluate changes in the transcriptome in response to linoleic acid (44), but our data show 
that it is not representative of S. aureus, in terms of its response to uFFA. MRSA 252 
belongs to a distinct clade within clonal complex CC30, characterized by accumulation of 
pseudogenes, and single nucleotide polymorphisms that attenuate virulence, and/or 
promote enhanced intrinsic resistance to antimicrobial agents (50,52,76). Conversely, 
WBG10049 is a hypervirulent CA-MRSA that belongs to a separate CC30 clade, and as 
with USA300, it exhibited robust induction of the SPC in response to linoleic acid. 
In summary, we conclude that induction of the SPC in response to uFFA is 
another factor that should now be considered in addressing the aggressive nature of skin 
and soft tissue infection caused by some strains of CA-MRSA, and as a general virulence 
mechanism for most strains of S. aureus. Future work will focus on the mechanistic 
details of induction, including evaluation of the USA300 transcriptome in response to 
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linoleic acid, evaluation of protease null mutants in bacteremia and subcutaneous wound 
infection models, and the significance of lipase processing by proteolytic activity. 
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CHAPTER 3 
 
 
Insights into the molecular events leading to the adaptation of  Staphylococcus 
aureus to unsaturated fatty acids 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.1      INTRODUCTION 
Staphylococcus aureus is a major human pathogen owing to its ubiquitous 
presence, antibiotic resistance, and its ability to infect virtually every tissue of the body 
68 
 
 
(1). Much research has gone into resolving the paradox that is inherent in the ability of S. 
aureus to exist both as a commensal, asymptomatically colonizing ~25% of the 
population (2), and an aggressive pathogen and a leading cause of infectious morbidity 
and mortality worldwide (3). Community acquired methicillin resistant S. aureus strain 
USA300, in particular, causes very aggressive skin and soft tissue infections (SSTI) and 
is the leading cause of visit to emergency departments in North America for the treatment 
of SSTIs (4-6).  
Colonization provides opportunity for infection, illustrated in the finding that 
patients with nosocomial S. aureus infection are typically infected by the same strain they 
are colonized with (7). Therefore, it is important to elucidate how signals encountered 
during colonization contribute to the survival of bacteria or the shift from colonization to 
infection. Colonization normally occurs in the anterior nares, but S. aureus may also 
colonize the warm, moist areas of the skin such as the axillae and perineum. Fatty acids 
are potent antimicrobials that are present on both the skin, through sebum, and in nasal 
secretions (8, 9), and thus we reason that in order to colonize the skin and anterior nares, 
S. aureus must have means of resisting their antimicrobial effects. Based upon results 
garnered in chapter 2, we undertook to further understand the response and resistance 
mechanisms of S. aureus to unsaturated fatty acids, using linoleic acid as a model fatty 
acid, on the basis of it being a major antimicrobial component of human nasal secretions 
(10), and also accumulating to millimolar concentrations within an abscess (11-13). 
Herein, we show that growth at subinhibitory concentrations of linoleic acid is 
associated with the processing of the secreted lipase Glycerol Ester Hydrolase (Geh) into 
its mature form, and that this processing is dependent on the metalloprotease aureolysin, 
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which is upregulated in response to linoleic acid. Although the inability to process lipase 
has no consequence on growth of USA300 in media containing linoleic acid, as 
determined from growth of an aureolysin- deficient mutant, we have isolated USA300 
variants with reduced susceptibility to linoleic acid, and have identified common single 
nucleotide polymorphisms (SNP) among these strains that may indicate candidate genes 
involved in fatty acid resistance. The research in this section contributes towards 
resolving the paradox that is inherent in the ability of S. aureus to exist as both a pathogen 
that is a leading cause of invasive skin and soft tissue infections, as well as a commensal 
organism that colonizes humans asymptomatically.  
 
 
 
 
 
 
 
 
 
 
3.2     MATERIALS AND METHODS 
3.2.1     Bacterial strains and growth conditions 
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Bacterial strains and plasmids used in this study are defined in Table 3.1. Cultures were 
maintained as frozen stocks (-80ºC) in 20% glycerol, and streaked on TSB agar when 
required. TSB was supplemented, when necessary, with 10μg/mL erythromycin or 
2μg/mL tetracycline for propagation of strains bearing resistance markers. 
Table 3.1 S. aureus strains used in this study 
Strain Description Source 
RN4220 Restriction deficient lab strain (14)  
DU5969 RN4220aur::lacZ; transcriptional fusion of lacZ to aur 
promoter 
(15)  
USA300 LAC Hypervirulent pandemic CA-MRSA Los Angeles 
county clone; clonal complex 8 
(16) 
Barry Kreiswirth 
USA300 USA300 LAC cured of antibiotic resistance plasmid This study 
USA300aur::lacZ Transduction of aur::lacZ from DU5969 donor  This study 
USA300sspABC Replacement of sspABC operon in USA300 with Tc
r
 
cassette, using pMJ232 
This study 
USA300aur Transduction of aur::lacZ into USA300 This study 
USA300sspABCaur Transduction of aur::lacZ into USA300sspABC This study 
 
3.2.2     Growth of S. aureus in fatty acids  
pMAD 
 
pDG1514 
Shuttle vector for the construction of 
mutations in Gram positive bacteria 
Source of Tc
r
 cassette 
                        (17) 
 
                        (18) 
pMJ232 pMAD containing Tc
r
 cassette from 
pDG1514, flanked by BamHI-[sspA-5P]-
MluI and EcoRI-[sspC-3P]-BglII 
                    This study 
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Linoleic acid (cis, cis-9,12-octadecadienoic acid; 18:2), was purchased from 
Sigma. Prior to supplementing TSB media, fatty acids were first mixed with an equal 
volume of DMSO, and then diluted in TSB to a working stock concentration of 5 mM.  
For growth analyses, bacteria from single colonies on TSB agar were inoculated into 
culture tubes containing 3 mL of antibiotic free TSB, and grown overnight at 37ºC on an 
orbital shaker, followed by measurement of OD600. A 25mL volume of TSB, 
supplemented with fatty acid where indicated, was then inoculated to achieve a starting 
OD600 of 0.01, and the cultures were grown at 37ºC in an orbital shaker incubator, set at 
180 rpm. Measurements of OD600 and samples of cell free supernatant were taken at 18 
hours of growth. 
3.2.3     Linoleic acid adaptation and genome sequencing 
USA300 (LAC, cured) was cultured into 3mL TSB and grown at 37
o
C overnight 
in an orbital incubator shaking at 250 rpm. OD600 was determined, and the bacteria were 
subcultured into 25mL TSB, or TSB supplemented with 50M linoleic acid to a starting 
inoculum corresponding to an OD600 of 0.01 in a 125mL Erlenmeyer flask. The bacteria 
were then grown at 37
o
C in an orbital shaker at 180 rpm until stationary phase, where the 
OD600 was determined. The bacteria were then subcultured into 25mL of TSB or TSB 
containing 50M linoleic acid, and grown to stationary phase. Cells were then plated on 
TSB agar, and single colonies were selected for preparation of stock cultures.  
For genome sequencing, genomic DNA from stock cultures was isolated using an 
Invitrogen PureLink
TM
 genomic DNA preparation kit. Samples of genomic DNA were 
sent to the London Regional Genomics Center for genomic sequencing using Ion Torrent 
Next-Generation sequencing. Pure genomic DNA from each of the control and adapted 
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clones were sent to the sequencing facility, where unique bar codes (Ion Xpress Barcode 
Adapter kit) for each clone were incorporated into the DNA, and sequencing was 
performed on an Ion Torrent 318 chip. After sequencing, reads from the same bar codes 
were aligned to the reference genome of USA300 FPR3757. SNPs were identified using 
the CLC Genomics Workbench software. 
3.2.4    TCA precipitation of proteins, SDS-PAGE, Western blotting and mass   
              spectrometry:  
For SDS-PAGE analyses, proteins in the cell-free culture supernatant were 
precipitated by mixing with an equal volume of ice-cold 20% TCA, washed in ice cold 
70% ethanol, then air dried and dissolved in SDS-PAGE reducing buffer. The culture 
density (OD600) was determined prior to preparation of cell-free culture supernatant, and 
for analysis of secreted protein profiles, TCA precipitated protein derived from 2.0 OD600 
units of culture was applied to each lane of a 12% acrylamide gel. Identification of 
Coomassie-Blue stained proteins was conducted at the London Regional Proteomics 
Centre at Western University. Protein bands were excised using an Ettan™ Spot Picker, 
and processed for mass spectrometry using a Waters MASSPrep Automated Digestor. 
Processed samples were spotted on MALDI plates and analyzed on an Applied 
Biosystems 4700 Proteomics Analyzer. Data were acquired and processed using 4000 
Series Explorer and Data Explorer (Applied Biosystems), and the peptide fingerprints 
were compared to the NCBInr database for Gram-positive bacteria, using the MASCOT 
search engine.  
For Western blotting, a volume of cell-free culture supernatant corresponding to 
0.02 OD600 units was mixed directly with SDS-PAGE reducing buffer, and applied to 
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10% polyacrylamide gels. Rabbit polyclonal antisera specific for SspA and Aur proteases 
was used, and rabbit polyclonal antiserum specific for Hla was purchased from Sigma. 
Blots were developed with donkey anti-rabbit IgG IR800 conjugate (Rockland 
Immunochemicals Inc.), and images were captured using an Odyssey infrared imager 
from LiCor Biosciences.  
3.2.5     Gas Chromatography Mass Spectrometry sample preparation 
mL of culture supernatant was collected for GC/MS analysis. The supernatants 
were acidified (pH < 2.0) with concentrated H2SO4. Fatty acids were then extracted three 
consecutive times with 750L of hexane, and the hexane extracts were then pooled 
together and dried under a constant stream of nitrogen gas. Dried samples were 
trimethylsilylated with 25L of pyridine and 25L of N,O-
bis(trimethylsilyl)trifluoroacetamide (BSFTA) + 1% Trimethylchlorosilane (TMS) 
(Sigma), and incubated at 70°C for 40 minutes.  
 
 
 
 
 
3.3     RESULTS 
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3.3.1    Metalloprotease aureolysin processes the Glycerol Ester Hydrolase (Geh) in   
             response to growth in linoleic acid 
It has been suggested in the literature that lipases are proteolytically processed 
into their mature form (19). The response to linoleic acid includes the upregulation of 
three proteases, SspA, SspB and aureolysin, as well as the processing of proGeh, as 
discussed earlier. Using isogenic protease mutants for the three proteases, we determined 
that USA300aur is the only single protease mutant defective for Geh maturation, and that 
USA300sspABC retains the ability to process lipase in the presence of linoleic acid (Fig 
3.1). We thus conclude that aureolysin is required for the processing of Geh. Arrows on 
the right of the SDS-PAGE gel indicate proteins identified by mass spectrometry. Both 
proSspB and mature Geh were detected in the same region (~40kDa) in the protein profile 
of wild-type USA300, and in the USA300sspABC mutant grown in the presence of 25M 
linoleic acid, only the mature Geh band protein was identified, while the mutant devoid of 
all SPC proteases does not produce a protein band in the region corresponding to proSspB 
or mature Geh, as expected. 
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Figure 3.1: Aureolysin is required for lipase processing 
SDS-PAGE of TCA precipitated protein from 18 hour culture supernatants of USA300 
(LAC, cured) and isogenic protease mutants grown in TSB (left) or TSB supplemented 
with 25M linoleic acid. Arrows indicate proteins identified by mass spectrometry. 
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3.3.2    USA300 adapts to growth in linoleic acid 
As noted in the previous chapter, USA300 undergoes a ~12 hour lag phase when 
grown in the presence of 50M linoleic acid, which is followed by of the resumption of 
exponential growth at a rate equivalent to that of growth in TSB alone. This observation 
is suggestive of an adaptive response by the bacteria, or selection of a naturally resistant 
mutant pre-existent in the culture. To advance upon these findings, we took stationary 
phase cultures that had grown in the presence of 50M linoleic acid, and subcultured 
them back into 50M linoleic acid again, and observed immediate induction of 
exponential growth, as opposed to a long lag phase (Fig 3.2 A, B). Importantly, these 
cells maintain their resistance to linoleic acid, even after passage through media lacking 
linoleic acid, and being frozen at -80
o
C. This alludes to a genetic adaptation, as opposed 
to an intrinsic response that is only manifested in the presence of linoleic acid. Despite 
permanent resistance to linoleic acid, the adapted cells did not exhibit any major changes 
in production of secreted virulence factors, and maintained their ability to induce protease 
expression in response to linoleic acid (Fig 3.2C), suggesting that adaptation to linoleic 
acid had likely not caused a mutation that is strongly influencing a major global regulator 
of virulence factors. 
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A      B 
 
 
 
 
C 
 
 
 
 
 
 
Figure 3.2: USA300 adapts to growth in linoleic acid. A) Growth of USA300 (LAC, 
cured) in TSB supplemented with 50M linoleic acid, and subcultured into B) 50M 
linoleic acid again. C) SDS-PAGE of the culture supernatants of wild type or cells 
passaged at the indicated concentration of linoleic acid, and then grown in TSB or TSB 
supplemented with 25M linoleic acid again for 18 hours.  
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3.3.3    Linoleic acid adapted cells contain SNPs in common genes 
Based on the phenotype of the linoleic acid adapted cells, we isolated genomic 
DNA from a single colony obtained from each of seven independently adapted cultures, 
along with two control cultures that had not been exposed to linoleic acid, and sent them 
to the London Regional Genomics facility at Robarts Research Institute for sequence 
determination on the Ion Torrent Next-Generation sequencing platform. Upon SNP 
analysis of the sequencing data, there were SNP mutations in all seven adapted cells that 
differed from the control cells, all resulting in amino acid substitutions. Importantly, five 
of the seven strains contained SNPs in two genes, highlighting these as candidates for 
linoleic acid resistance. Table 3.2 lists the SNPs identified in the seven adapted strains 
and the corresponding amino acid substitutions. With SNPs in three separate isolates, 
USA300_1179 is a ribonuclease gene, cvfA, which may be involved in mRNA 
degradation and subsequently may control post-transcriptional modification of gene 
expression. Interestingly, USA300_1126 is also a ribonuclease, rnc, which is involved in 
dsRNA degradation. US300_2490 is a member of the TetR family of transcriptional 
repressors, and two of the isolates contained SNPs causing the same amino acid 
substitutions.  
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Table 3.2: Single Nucleotide Polymorphisms in linoleic adapted strains of USA300 
Clone       Gene Number Nucleotide  
Substitution 
Amino Acid 
Substitution 
Coverage/Frequency 
1   USA300_1179  1298394 
C>T  
Leu269Phe 65x/100%  
2   USA300_1179  1298586 
C>A 
Gln333Lys 14x/100%  
3   USA300_1179  1298427 
C>T 
Pro280Ser 24x/100%  
4   USA300_2057  2220605 
T>C 
Glu160Gly 31x/100%  
5   USA300_1126  1232458 
T>C 
Ser207Pro 14x/100%  
6   USA300_2477  2676139 
G>A 
His82Tyr 19x/100%  
6   USA300_2490  2692995 
C>T 
His121Tyr 31x/100%  
7   USA300_2490  2692995 
C>T 
His121Tyr 18x/100%  
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3.3.4    Fate of linoleic acid in culture media 
To determine if a change in the concentration or composition of linoleic acid was 
coinciding with the end of lag phase growth in 50M linoleic acid, the concentration of 
linoleic acid in culture media throughout the lag phase was assessed using gas 
chromatography-mass spectrometry (GCMS). From samples taken throughout the lag 
phase and in stationary phase, it was determined that linoleic acid concentrations remain 
high, up to the beginning of exponential phase growth, but no linoleic acid was detected 
in the stationary phase culture. This indicates that the initiation of exponential growth is 
not reliant upon a decrease in the linoleic acid concentration, and also that the linoleic 
acid is being removed from, or modified in the culture media during exponential phase 
growth (Fig 3.3).  
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Figure 3.3: Linoleic acid disappears from culture media during exponential phase 
growth of USA300. Growth curve of USA300 (LAC, cured) in TSB supplemented with 
50M linoleic acid. Red circles indicated time points at which samples for GCMS were 
taken. The legend below represents the presence (+) or absence (-) of linoleic acid in 
culture media. 
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3.4    DISCUSSION 
In this chapter, we have demonstrated that aureolysin is responsible for processing 
proGeh into its mature form, that USA300 adapts to growth in the presence of inhibitory 
concentrations of linoleic acid, and that this adaptation appears to be facilitated by SNPs 
in a limited number of genes, which are predicted to cause amino acid substitutions in the 
encoded gene products. We have also determined that linoleic acid is being modified or 
removed from the culture medium during growth of bacteria. Together, these results add 
evidence to this research that is leading towards our ultimate goal of determining how S. 
aureus is able to grow in the presence of antimicrobial fatty acids, and determining the 
significance of the response of S. aureus to fatty acids. To that end, the observation that 
proGeh is activated by aureolysin upon linoleic acid stimulation is intriguing. Literature 
has suggested that proGeh and mature Geh do not significantly differ in their ability to 
hydrolyze lipids (20), but these conclusions were drawn from analysis of SDS-PAGE 
zymogram assays, in which the propeptide of an inactive precursor may be incorrectly 
positioned, and thus the enzyme may be active in this assay. Demonstration of this effect 
can be made with precursor SspB, wherein a zymogram assay the proenzyme appears to 
be active, but has much reduced activity in biochemical assays using proper buffers and 
pure protein (21). Despite this controversy, we are unable to report any difference in the 
lipolytic activity of whole supernatants lacking the aureolysin convertase, and thus 
lacking the active lipase. However, there are additional lipases in the USA300 genome 
that may be performing a compensatory function. Another possibility is that the activity 
of mature Geh differs from its proprotein in terms of the reaction it catalyzes. Enzymes in 
general have a tendency to be able to perform the reverse reaction, typically when placed 
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in an environment that is sub-optimal. Interestingly, the activity of Geh is optimal at a 
high pH, and has almost no lipase activity at the pH found on the skin (19, 20, 22). 
FAME, however, has a low optimal pH and almost no FAME activity at the pH optimal 
for a lipase (23). Since FAME and Geh perform the reverse reaction of one another, one 
must consider the possibility that Geh is performing its reverse reaction by esterifying 
fatty acids to cholesterol molecules in low pH environments. 
In addition to the induction of expression of secreted proteases, concomittant with 
maturation of lipase precursor, we have also demonstrated adaptation at the chromosomal 
level in response to linoleic acid. Two fields of view exist with regards to evolution of 
this kind. The classical Darwinian evolution would suggest that there are naturally 
occurring mutations that exist within the population of bacteria, and only the cells with 
mutations conferring linoleic acid resistance will survive under this selective pressure. 
Under this view, we are selecting for naturally occurring variants that were present in the 
original inoculum, and the observed lag phase comprises the time required for these few 
bacteria to multiply and surpass the cell density of the starting inoculum. The other view 
is that the bacteria are able to alter their genome in response to linoleic acid, and that this 
alteration allows them to survive. In support of this theory, literature has demonstrated 
that the production of reactive oxygen species in response to antibiotic treatment causes 
random mutations in chromosomal DNA, and certain random mutations confer resistance 
to the antibiotic (24). Although we have no direct evidence of either theory, the genes 
targeted in the linoleic acid resistant mutants will provide clues to the mechanism of 
resistance to and antimicrobial mechanism of fatty acids. Six of eight SNPs were 
occurring in genes that may control transcriptional and post-transcriptional regulation. 
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USA300_2490 is of the TetR family of transcriptional repressors, and thus a gain or loss 
of function in that gene as a result of a SNP would have downstream consequences on 
genes that are regulated by TetR. Likewise, if the ribonucleases CvfA and Rnc are 
involved in mRNA stability, a shift in the expression of genes could be occurring post-
transcriptionally as a result of SNP induced alteration in the function of these 
ribonucleases. Although this theory is merely speculation at this juncture, further 
experiments will include a transcriptome analysis in response to linoleic acid to identify 
mRNAs that are being affected in response to linoleic acid. 
 Determination of linoleic acid concentration in culture media throughout growth is 
a necessary step in elucidating the Staphylococcal response to fatty acids, because it 
provides further knowledge into how the bacteria are physically coping with the lipid. 
The finding that linoleic acid concentration remains constant throughout the lag phase, up 
to the initiation of exponential growth is important, because it demonstrates that 
exponential growth is initiated in the presence of an inhibitory concentration of linoleic 
acid, further emphasizing our adaptation theory. It is also important because it shows that 
the lipid is not being spontaneously broken down in culture media. Literature has 
suggested that although S. aureus does not synthesize its own unsaturated fatty acids (25), 
it is capable of incorporating endogenous fatty acids into is phospholipid bilayer (26, 27). 
Therefore, next steps in this experiment will be to determine the fatty acid composition of 
the bacterial cell membrane during exponential growth in medium containing 
supplementary fatty acid, and to determine if the membrane composition is altered in cells 
that have adapted to growth at an inhibitory linoleic acid concentration. 
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CHAPTER 4 - GENERAL DISCUSSION AND FUTURE DIRECTIONS 
The main findings of this research on the Staphylococcus aureus response to 
antimicrobial fatty acids can be roughly divided into two main observations; i) The 
upregulation of the staphylococcal proteolytic cascade upon exposure to unsaturated fatty 
acids, and ii) Adaptation to linoleic acid. Based on the data in chapters 2 and 3, these two 
observations are seemingly independent of each other; meaning that even non-adapted 
strains display increased protease expression upon exposure to subinhibitory 
concentrations of fatty acid, and regardless of whether the strain has adapted to growth in 
linoleic acid or not, presence of the fatty acid in culture media is still essential to induce 
increased expression of the SPC. In addition, we report that the upregulation of the SPC, 
specifically aureolysin, results in proteolytic processing of the glycerol ester hydrolase 
into its mature form, and that this response is characteristic of hypervirulent community 
acquired strains, and not present in some strains that are commonly used to study 
Staphylococcal pathogenesis.  
Induction of the SPC and processing of proGeh may be regarded as a dynamic 
adaptive response to fatty acids, as it only occurs in the presence of fatty acids, and the 
expression of proteases returns to normal upon growth in media without fatty acid. 
GCMS data from chapter 3 are also indicative of an adaptive response because it suggests 
that the bacteria are removing fatty acid from the media by an as of yet unknown 
mechanism. Together, we can conclude that USA300 responds to fatty acids by 
increasing the expression of the SPC, maturation of Geh and removal of fatty acids from 
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culture media. As opposed to this dynamic adaptive response, it is unlikely that the SNPs 
discovered after growth in fatty acids represent an adaptive response to fatty acids. If this 
were the case, one would expect that these SNPs would be found in nature, occurring in 
bacteria isolated from areas of high fatty acid concentration such as the anterior nares, 
and an abscess. Rather, these SNPs that allow growth in high concentrations of fatty acids 
were likely selected for, and may enlighten us further about the mechanism of 
antimicrobial activity of the fatty acid, and how the bacteria respond to the fatty acid. 
More experiments will have to be conducted on these SNPs in order to speculate on the 
mechanism of resistance in these adapted strains. Specifically, to determine whether 
SNPs are causing loss- or gain-of-function mutations in each gene, SNP containing genes 
will be cloned into wild type USA300, and in turn, wild type genes will be cloned into 
mutated USA300 strains. In each case, resistance to fatty acids will be determined. More 
adaptation experiments will also be done to determine the frequency, and thus 
importance, of each SNP in conferring resistance to fatty acids.  
An important avenue to pursue will also be the fate of linoleic acid in culture 
media. In addition to the knowledge that fatty acids are removed from the media, 
determining the mechanism of this removal, and destination of the fatty acid beyond that 
point will be illuminating. As stated in chapter 3, we expect to observe that the fatty acids 
are being incorporated into the phospholipid bilayer of the bacteria, and determination of 
the bacterial membrane lipid composition during growth in fatty acids will be done using 
GCMS.  
Finally, it will be informative to determine the consequence of the processing of 
proGeh discussed in both chapters 2 and 3. We have no evidence at this point as to 
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whether or not processing is necessary to confer or alter activity of the lipase, and thus the 
next step will be to purify both the precursor and mature forms. Further, one wonders 
whether this maturation confers increased resistance to fatty acids, or more likely, 
increased survival in areas of a more complex lipid composition such as sebum, and 
within an abscess. Survival assays using wild type USA300, and proGeh maturation 
deficient USA300aur in full human sebum, or in skin colonization models, would help to 
further elucidate the significance of this marked response to fatty acids.  
The work presented here consists mainly of descriptive data demonstrating the 
response of community acquired methicillin resistant S. aureus to long chain fatty acids. 
Because the data presented represents novel observations and branches in several 
different directions, this work provides a strong base for future research in each avenue, 
which will consist of elucidating the mechanism behind, and consequence of, each of the 
responses presented here. The impact of CA-MRSA currently as a pathogen, as well as 
the threat it presents as an emerging pathogen is incontrovertible, and therein lies the 
significance of this research.  
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APPENDIX 
Structures of fatty acids 
 
Linoleic acid (C18:2) 
 
 
Oleic acid (C18:1) 
 
 
Linolenic acid (C18:3) 
 
 
Stearic acid (C18:0) 
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Sapienic acid (C16:16) 
 
 
Palmitoleic acid (C16:1

 
Palmitic acid (C18:0) 
 
 
Glycerol monolaurate 
 
 
1-Linoleoyl glycerol 
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